BRD2 induces drug resistance through activation of the RasGRP1/Ras/ERK signaling pathway in adult T‐cell lymphoblastic lymphoma
Xiao‐Peng Tian(Sun Yat-sen University), Qingqing Cai(Sun Yat-sen University)
Cited by 51
Related Papers
Expression and clinical value of programmed cell death-ligand 1 (PD-L1) in diffuse large B cell lymphoma: a retrospective study
|Chinese Journal of Cancer|2017|56
Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study
|The Lancet Oncology|2023|55
PHB promotes bladder cancer cell epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway
|Pathology - Research and Practice|2023|23